Objective. Case reports and short-term clinical trials have suggested that treatment for
chronic hepatitis B (CHB) may lead to improvement of cirrhosis. The aim of the present study …

Aim: To evaluate the association between liver stiffness measured by transient elastography
(FibroScan) and the efficacy of long‐term nucleoside analog (NA) treatment for patients with …

ABSTRACT Background/Aims: The usefulness of liver stiffness measurement (LSM) for
monitoring changes in fibrosis and inflammation in chronic hepatitis B (CHB) patients …

Background Liver stiffness (LS) has been reported to correlate with fibrosis stage (F). The
correlation between LS and fibrosis stage and the reduction of LS by antiviral therapy were …

Aim: The usefulness of transient elastography remains to be validated in chronic hepatitis B,
particularly as a tool for monitoring the degree of liver fibrosis during treatment. Methods …

This is a retrospective single-center study that included 87 subjects. All subjects had chronic
hepatitis B or HBV cirrhosis and underwent nucleos (t) ide analogs (NUC) treatment for more …

Background Factors influencing changes in liver stiffness measurements during long‐term
nucleoside analogue therapy for chronic hepatitis B (CHB) have not been thoroughly …

Abstract Background and Aim Little reliable data are available about the liver stiffness
measurement (LSM) for fibrosis monitoring in chronic hepatitis B (CHB) patients on antiviral …

Purpose The aim of this study was to evaluate the effects of antiviral therapy on liver stiffness
measurement (LSM). Methods Two hundred HBV patients were enrolled from four hospital …

Abstract Background & Aims Liver stiffness (LS) measurement using transient elastography
allows for accurate evaluation of liver fibrosis in patients with chronic liver disease. We …